Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
July 24, 2020

Medical devices industry deals in Q2 2020 total $8.51bn globally

Total medical devices industry deals for Q2 2020 worth $8.51bn were announced globally, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked a decrease of 52.9% over the previous quarter and a drop of 44.4% when compared with the last four-quarter average of $15.34bn.

In terms of number of deals, the sector saw a rise of 3.8% over the last four-quarter average with 438 deals against the average of 422 deals.

In value terms, North America led the activity with deals worth $4.72bn.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

Medical devices industry deals in Q2 2020: Top deals

The top five medical devices deals accounted for 41.1% of the overall value during Q2 2020.

The combined value of the top five medical devices deals stood at $3.49bn, against the overall value of $8.51bn recorded for the month.

The top five medical devices industry deals of Q2 2020 tracked by GlobalData were:

1) InVitae’s $1.4bn acquisition of ArcherDx

2) The $1bn venture financing of MGI Tech by Citic Private Equity Funds Management, CITIC Securities, CPE Capital, GF Xinde Investment Management, Guotai Junan Securities, Huatai Zijin Investment, Huaxing New Economic Fund, IDG Capital, Shanghai Guofang Mother Fund, ShenZhen Co-Stone Asset Management and Shenzhen Green Pine Capital Partners

3) Canada Pension Plan Investment Board, Illumina and Public Sector Pension Investment Board’s $390m venture financing of Grail

4) The $367.87m private equity deal with Fuzhou Maixin Biotechnology Development by Beijing Strong Biotechnologies and Sinopharm Group

5) The Blackstone Group’s private equity deal with Medtronic for $337m.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

 

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU